Latest News
Palantir stock is up close to 60% this year already.
Via The Motley Fool · May 1, 2025
Via The Motley Fool · May 1, 2025
Via The Motley Fool · May 1, 2025
The Relative Strength (RS) Rating for Trane Technologies stock entered a new percentile Thursday, with a rise from 71 to 86.
Via Investor's Business Daily · May 1, 2025
Britain's main stock index remained relatively steady on Thursday as investors weighed various corporate earnings, a U.S.-Ukraine minerals agreement, and the potential for a trade deal with China.
Via Talk Markets · May 1, 2025
Lower-income consumers are already struggling, and the end of the de minimis exemption will make things even harder.
Via The Motley Fool · May 1, 2025
There was a wave of good news for the artificial intelligence (AI) chipmaker.
Via The Motley Fool · May 1, 2025
Fresh off monthly losses, the Dow Jones Industrial Average and Nasdaq Composite Index are both up over 400 points this afternoon, while the S&P 500 Index sits firmly higher as well.
Via Talk Markets · May 1, 2025
Rosenblatt analyst maintains Buy rating and $263 price target for Apple despite policy challenges and potential revenue upside in fiscal second-quarter earnings report.
Via Benzinga · May 1, 2025
Via Benzinga · May 1, 2025

Initial claims rose 18,000 to 241,000, the highest since February 22. The four week moving average rose 5,500 to 226,000.
Via Talk Markets · May 1, 2025
Oil demand expectations have decreased, influenced by OPEC’s potential production increase and slowing demand. U.S. oil producers saw prices close above $58 a barrel yesterday, a critical marker.
Via Talk Markets · May 1, 2025
Moderna reaffirms 2025 revenue guidance of $1.5 billion–$2.5 billion, cuts 2027 cost forecast by up to $1.7 billion, and targets 2026 approval for its flu/COVID combo shot.
Via Benzinga · May 1, 2025
Via Benzinga · May 1, 2025
Via Benzinga · May 1, 2025